doi.org/10.1016/j.annonc.2021.05.570

MO4-7 Efficacy and safety with selpercatinib in patients with RET fusion+ NSCLC: Analysis by last prior systemic therapy

,

Oliver Gautschi

,

..., Benjamin Besse

Annals of Oncology50.50

Volume: 32, Pages: S297 - S297

Published: Jul 1, 2021

Abstract

No abstract.

Paper Fields

Paper Details

Title

MO4-7 Efficacy and safety with selpercatinib in patients with RET fusion+ NSCLC: Analysis by last prior systemic therapy

DOI

doi.org/10.1016/j.annonc.2021.05.570

Published Date

Jul 1, 2021

Journal

Annals of Oncology

Volume

32

Pages

S297 - S297

Citation AnalysisPro

You’ll need to upgrade your plan to Pro

Looking to understand the true influence of a researcher’s work across journals & affiliations?

Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.

Notes

History